Clinical Trials Browser

Phase 1/2 × Lymphoma, Mantle-Cell × ixazomib × Clear all

NCT03323151 2024-01-18

PrE0404

Phase 1/2 Completed

43 enrolled 21 charts

Lymphoma, Mantle-Cell

NCT02632396 2023-05-09

Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission

Phase 1/2 Unknown

Lymphoma, Mantle-Cell